Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Tempest Therapeutics, Inc. (OVAS)
|
|
Balance Sheet |
|
|
|
Standardized | As Reported |
Annual | Quarterly |
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
Assets |
Cash and equivalents | 17.6 | 22.9 | 31.2 | 42.8 | 51.6 | 45.8 | 51.8 | 59.7 |
Other current assets | 0.9 | 1.7 | 1.7 | 17.5 | 16.7 | 17.0 | 17.1 | 2.8 |
Total current assets | 18.5 | 24.7 | 33.0 | 60.3 | 68.3 | 62.7 | 69.0 | 62.6 |
Property, plant, and equipment, net | 1.0 | 1.0 | 1.1 | 0.9 | 1.0 | 1.0 | 1.1 | 1.1 |
Other fixed assets | 0.4 | 0.4 | 0.4 | 0.7 | 0.5 | 0.5 | 0.1 | 0.1 |
Total assets | 30.7 | 37.3 | 46.1 | 63.2 | 71.4 | 67.0 | 73.2 | 67.1 |
|
Accounts payable | 0.9 | 1.2 | 1.1 | 0.9 | 1.4 | 0.7 | 1.0 | 2.4 |
Accrued expenses | 2.5 | 2.5 | 3.0 | 16.1 | 15.6 | 15.3 | 15.9 | 1.7 |
Short-term and curr portion of long-term debt [+] | 3.0 | 1.5 | 0.0 | 3.5 | 2.0 | 0.0 | 0.0 | 0.0 |
Short-term debt | | | | 3.5 | 2.0 | | | |
Current portion of long-term debt | 3.0 | 1.5 | | | | | | |
Other current liabilities | 2.3 | 2.3 | 3.2 | 3.6 | 3.3 | 4.8 | 3.1 | 2.2 |
Total current liabilities | 8.6 | 7.5 | 7.3 | 24.1 | 22.4 | 20.8 | 20.0 | 6.2 |
Long-term debt | 7.5 | 8.9 | 10.4 | 11.8 | 13.3 | 15.1 | 15.1 | 15.0 |
Other liabilities | 9.6 | 9.9 | 10.3 | 0.5 | 0.7 | 1.6 | 2.0 | 2.4 |
Total liabilities | 25.7 | 26.4 | 28.0 | 36.4 | 36.4 | 37.6 | 37.1 | 23.6 |
|
Shareholders' equity [+] | 5.0 | 11.0 | 18.1 | 26.8 | 34.9 | 29.4 | 36.1 | 43.5 |
Paid-in capital | 156.0 | 154.4 | 153.9 | 153.4 | 152.6 | 137.9 | 136.2 | 135.9 |
Retained earnings | -151.0 | -143.4 | -135.8 | -126.7 | -117.7 | -108.6 | -100.1 | -92.3 |
Tangible shareholders' equity | 5.0 | 11.0 | 18.1 | 26.8 | 34.9 | 29.4 | 36.1 | 43.5 |
|